BRILL ANNOUNCES ENTRY INTO THE US PHARMACEUTICAL MARKET STARTING WITH NEW DISRUPTIVE MEDICAL DEVICE IN OPHTHALMOLOGY OF ITS OWN DEVELOPMENT
April 2, 2024by admin
BRILL NEWS
HomeAuthor
admin - Brill ASIA
May 26, 2020 Sonoma Pharmaceuticals Announces Expanded Distribution Agreement with Brill International S.L. for Europe and approval of new CE Marking for Microdacyn60® Eye Care
Brill International is a pharmaceutical company specialized in the commercialization of pharmaceutical products within the ophthalmology segment.
Copyright 2024, BRILL INTERNATIONAL. All rights reserved. Privacy Policy
